Home › NDC Lookup › RxCUI directory › RxCUI 864650

Ganciclovir 0.0015 MG/MG Ophthalmic Gel [Zirgan] — RxCUI 864650

RxNorm drug concept · Semantic branded drug
RxCUI 864650 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI864650
Official nameGanciclovir 0.0015 MG/MG Ophthalmic Gel [Zirgan]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asZirgan 0.15 % Ophthalmic Gel; Zirgan 0.0015 MG/MG Ophthalmic Gel
FDA products mapped1
Package NDCs mapped2
Reported Medicaid activity (SDUD)1,891 prescriptions · 18 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Ganciclovir: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Ganciclovir is an antiviral that stops certain viruses from copying themselves. The injection form is used mainly to treat or prevent CMV (cytomegalovirus) infections — a serious v...
  • Why has my doctor prescribed ganciclovir — what exactly does it do?
  • The most important ones to watch for with the injection form are signs of low blood counts — things like unusual bruising, bleeding gums, persistent fever, or feeling unusually wea...
  • What side effects should I actually watch out for?
📖 Read our full Ganciclovir guide →

🕸️ Concept Web — How Ganciclovir 0.0015 MG/MG Ophthalmic Gel [Zirgan] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Ganciclovir 0.0015 MG/MG Ophthalmic Gel [Zirgan] RxCUI 864650

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Ganciclovir 4678
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Zirgan 864647
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Ganciclovir Ophthalmic Gel 393324
    • Ganciclovir Ophthalmic Product 1163918
    • Ganciclovir Ophthalmic Gel [Zirgan] 864649
    • Zirgan Ophthalmic Product 1187668
    • Ophthalmic Gel 316963
    • Ophthalmic Product 1151135
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

  • Ganciclovir 0.0015 MG/MG [Zirgan] SBDC · 864648
  • Ganciclovir Ophthalmic Gel [Zirgan] SBDF · 864649
  • Zirgan Ophthalmic Product SBDG · 1187668
  • Zirgan BN · 864647

📦 FDA Products & Package NDCs

1 product · 2 package NDCs
2 package NDCs map to RxCUI 864650 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
24208-0535-15 1 TUBE, WITH APPLICATOR in 1 CARTON (24208-535-15) / 1.5 g... ZIRGAN Bausch & Lomb Incorporated 2010-04-30
24208-0535-35 1 TUBE, WITH APPLICATOR in 1 CARTON (24208-535-35) / 5 g in... ZIRGAN Bausch & Lomb Incorporated 2010-04-30
Observed labelers: Bausch & Lomb Incorporated (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per gm · median
$91.3192
Range $91.3192–$91.3192 · middle 50% $91.3192–$91.3192 · 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.